In a recent study researchers have devised a machine learning algorithm which combines three variables routinely collected during clinic visits and demonstrates how the emerging field of bioinformatics could transform patient care. It takes a patient age urinary albumin/creatinine ratio (UACR) and cardiovascular disease history to successfully identify hypertensive patients for whom the benefits of intensive therapy outweigh the risks. Large randomized trials have provided inconsistent evidence regarding the benefit of intensive blood pressure lowering in hypertensive patients said a researcher Yang Xie. To the best of our knowledge this is the first study to identify a subgroup of patients